More than 15 distributors, procurement platforms, and analytics providers have joined the ACT Ecolabel Channel Partner network, bringing independently verified sustainability data to the point where labs make purchasing decisions. Learn how this growth connects to new EU rules on environmental claims taking effect September 27, 2026, and what they mean for suppliers and buyers across the lab supply chain.
My Green Lab says thank you to Penny James, a champion of the organization’s mission, as she steps down from the Board after retiring from AstraZeneca. Meet Liz Chatwin, AstraZeneca’s Vice President of Sustainability and Global SHE, who joins the Board with nearly 30 years of pharmaceutical industry experience.
The Pharmaceutical Supply Chain Initiative (PSCI) has endorsed My Green Lab’s Converge Supplier Initiative, a collaboration helping CROs, CMOs, and CDMOs earn My Green Lab Certification and reduce Scope 3 emissions. Read how more than 147 supplier organizations and leading pharma companies are working together to bring sustainable practices to labs across the supply chain.
Need a little good news? This Earth Day roundup highlights five sustainability wins from around the world, including California running on renewable power, The Ocean Cleanup’s record trash removal, and France’s move to ban PFAS in consumer products. Read on for a dose of inspiration, plus the vertical farms and public transit projects that show real progress is underway.
Impact Laboratories, the third-party verifier of My Green Lab Certification, has raised $4.95 million in Series A funding, surpassing its target. Read how the investment will fuel new enterprise sustainability tools and expand global adoption of My Green Lab Certification and the ACT Ecolabel, plus what the investors behind the round are saying.
The U.S. EPA has added both My Green Lab Certification and the ACT Ecolabel to its Environmentally Preferable Purchasing recommendations, a milestone that recognizes the rigor behind each program. Find out what this means for federal purchasers, and how the recognition supports the push to make green labs the global standard.
Biotech and pharma have reached a tipping point on climate action, but the biggest challenge still lies in the supply chain. Dive into My Green Lab’s 2024 Carbon Impact Report, released at COP 29, to see how far the industry has come on emissions targets and why Scope 3 is the next frontier.
This report released during COP28 shows an increase in the sector's Race to Zero commitments while highlighting the need for increased action in scope 3 reductions and collaborative supply chain engagement
